SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-08-001122
Filing Date
2008-01-14
Accepted
2008-01-14 18:33:40
Documents
1
Period of Report
2008-01-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 20511
  Complete submission text file 0001179110-08-001122.txt   22539
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address 7000 SHORELINE COURT SUITE 270 SO. SAN FRANCISCO CA 94080 2062817001
PONIARD PHARMACEUTICALS, INC. (Issuer) CIK: 0000755806 (see all company filings)

IRS No.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 750 BATTERY ST STE 600 SAN FRANCISCO CA 94111
Business Address 410 WEST HARRISON ST SEATTLE WA 98119-4007 2062817001
CRAVES FRED B (Reporting) CIK: 0001014095 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-16614 | Film No.: 08529540